DEA Hearing on Marijuana Reclassification Begins
The hearing will weigh medical evidence and public health risks as supporters say rescheduling could expand research and affect 3.7 million patients.
- The Drug Enforcement Administration began formal proceedings today at its Arlington, Virginia, headquarters to discuss reclassifying marijuana from Schedule I to Schedule III of the Controlled Substances Act.
- Expanding use across the United States includes 3.7 million medical patients, while 40 states allow medical cannabis programs and 24 states have legalized recreational marijuana despite its federal status.
- Physician Patricia Hurford said rescheduling could "provide greater legitimacy and consistency for patients," though she cautioned that "significant challenges remain," including a lack of high-quality clinical trials.
- Kevin Sabet, CEO of Smart Approaches to Marijuana, argued rescheduling would primarily benefit the industry by allowing tax deductions, claiming, "We would be giving a tax break to companies that have become the new Big Tobacco."
- Trump accelerated the review process with an executive order in December; the proceedings are not expected to extend beyond July 15, potentially affecting future banking access and medical prescriptions.
12 Articles
12 Articles
Mid Florida Newspapers
Weatherford DemocratHow Millions in Political Donations Push for DEA Marijuana Rescheduling
While DEA's marijuana rescheduling hearing proceeds with participants for and against rescheduling, MMJ International Holdings highlights publicly disclosed political spending by major state licensed cannabis companies-and a federal cultivation application that has remained unresolved since 2018.
Marijuana Activists Say They're Being 'Shut Out' Of DEA's Rescheduling Hearing That Features Only Legalization Opponents
A coalition of marijuana legalization activists gathered outside Drug Enforcement Administration (DEA) headquarters on Monday ahead of the start of a hearing an agency judge is overseeing on the Trump administration’s proposal to reschedule cannabis—criticizing the fact that no supporters of reform were invited to participate and that the proceedings are not being livestreamed despite […]
Straight Arrow News
ussanews.comDEA hearing on proposed federal marijuana rescheduling to begin Monday
A long-awaited federal hearing on whether marijuana should be reclassified under U.S. drug law is set to begin Monday, marking a pivotal step in a debate that has divided physicians, policymakers and advocacy groups over the drug's medical value, public health risks and regulatory future. The U.S. Drug Enforcement Administration said formal proceedings on the proposed move to reclassify marijuana from Schedule I to Schedule III of the Controlle…
DEA Begins Cannabis Rescheduling Hearing Amid Restrictions on Public and Proponent Participation - MedicateOhio
The Drug Enforcement Administration (DEA) officially commenced formal administrative proceedings today, June 29, 2026, to evaluate the proposed reclassification of cannabis under the Controlled Substances Act (CSA).
Coverage Details
Bias Distribution
- 57% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
